Efamol GAIT PR Coverage
Effects of Treatment on Cognition and Mobility
Click here to view PDF
Omega-3 intake prevents age-related macular degeneration
The latest review of the science linking omega-3 intake to lower incidence of age-related macular degeneration (AMD) has concluded that the potential therapeutic benefit of omega-3 fatty acid supplementation is supported by the role of these fatty acids in normal retinal physiology, their anti-inflammatory properties, and the putative role of inflammation in AMD1. However, since […]
Health benefits from fish intake may be attributed to a combination of selenium and omega-3 fatty acids
A recent study has looked at the relationship between omega-3 fatty acids and selenium intake relative to health benefits in the elderly. This study, supported by a grant from the French Alzheimer’s disease association was carried out under agreement between the Merck, Sharp and Dohme-Chibret Laboratories and EISAI laboratory, France. It provided evidence that […]
DHA Supplementation During Pregnancy Benefits Mother and Infant
The largest clinical study ever providing DHA to pregnant women has reported a reduction in postnatal depression relative to in the general population and substantial health benefits to their infants. The study, supported by a grant from the Australian National Health and Medical Research Council and completed with capsules donated by Efamol Ltd., UK, […]
Fish oil fatty acids and anti-oxidant nutrients reduce risk of age-related macular degeneration in people with a genetic susceptibility
A new study found that among people with a genetic susceptibility to age-related macular degeneration (AMD), those who ate more zinc, beta-carotene, lutein/zeaxanthin and the omega-3 eicospaentaenoic acid (EPA) and docosahexaenoic acid (DHA) cut their risk of developing the condition by up to a third compared with those who ate less of these nutrients. AMD […]
High dietary intake of EPA/DHA, zinc, beta-carotene and lutein/zeaxanthin reduces the risk of early AMD in people with high genetic risk of developing the condition
Topics: Omega-3 fatty acids, docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), long chain polyunsaturated fatty acids (LC-PUFAs), age-related macular degeneration (AMD), zinc, anti-oxidants, Vitamins A, C & E, beta-carotene, lutein/zeaxanthin. Objective: To investigate whether omega-3 fatty acids, zinc, Vitamins A, C & E, beta-carotene and lutein/zeaxanthin can reduce the genetic risk of early AMD conferred by […]
New study shows Omega-3s reduce admission to hospital and deaths from heart failure
The first large scale clinical trial assessing the effects of omega-3 fatty acids on risk reduction in cardiac patients has measured significant benefits. The study, dubbed the GISSI-HF Trial (Gruppo Italiano per lo Studio della Soprevvivenza nell’Infarto miocardico) included 6975 patients from 326 cardiology and 31 internal medicine centres in Italy. All had chronic heart […]
Questions on Fish Oil, Sustainability and the Environment
Q. What is your position on global overfishing? A. Global overfishing is a major concern that is currently being taken very seriously by countries around the world. Boris Worm from Dalhousie University, Halifax, Nova Scotia, brought the issue to a head in Nov 2006 when he and 13 other scientists from Canada, the United States, Britain, […]
EPO, Hexane Extraction and the Environment
Q. Why would a company use hexane in their processing, a volatile organic compound (VOC) that can be an environmental pollutant if incorrectly handled? A. Hexane is not classified as a ‘greenhouse gas’ by the Intergovernmental Panel on Climate Change (see http://www.answers.com/topic/ipcc-list-of-greenhouse-gases-1 ) and is therefore not considered to be a major climate changing pollutant. To date, hexane […]